In the week since a line of Japanese health supplements began being recalled, five people have died and more than 100 people were hospitalised as of Friday.
Osaka-based Kobayashi Pharmaceutical Co. came under fire for not going public quickly with problems known internally as early as January. The first public announcement came March 22.
